Terms: = Lung cancer AND BAP1, DKFZp686N04275, 8314, ENSG00000163930, Q92560, KIAA0272, hucep-6, HUCEP-13, FLJ37180, FLJ35406 AND Diagnosis
123 results:
1. bap1, Wilms' tumor 1, and calretinin in predicting survival and response to first-line chemotherapy in patients with pleural mesothelioma.
Yuce TH; Ak G; Metintas S; Dundar E; Roe OD; Panou V; Metintas M
J Cancer Res Clin Oncol; 2024 Jan; 150(2):38. PubMed ID: 38280040
[TBL] [Abstract] [Full Text] [Related]
2. Investigation of MTAP and bap1 staining loss and P16/CDKN2A deletion in pleural cytology specimens and its role in the diagnosis of mesothelioma.
Şeker NS; Tekin E; Ak G; Metintaş M; Metintaş S; Dündar E
Diagn Cytopathol; 2024 Apr; 52(4):211-216. PubMed ID: 38243885
[TBL] [Abstract] [Full Text] [Related]
3. Methylthioadenosine Phosphorylase and Breast cancer 1 Protein-Associated Protein 1 as Biomarkers for the Peritoneal Mesothelioma.
Chen Y; Du X; Gao Y; Wu H; Zhao H; Su Y
Cancer Control; 2023; 30():10732748231220805. PubMed ID: 38092371
[TBL] [Abstract] [Full Text] [Related]
4. Mesothelioma in situ of the peritoneum: report of three cases and review of the literature.
Symes E; Tjota M; Cody B; Kindler H; Mitchell O; Witmer H; Turaga K; Mueller J; Krausz T; Husain AN; Li H
Histopathology; 2024 Feb; 84(3):492-506. PubMed ID: 38084880
[TBL] [Abstract] [Full Text] [Related]
5. Combined Inhibition of EZH2 and FGFR is Synergistic in bap1-deficient Malignant Mesothelioma.
Badhai J; Landman N; Pandey GK; Song JY; Hulsman D; Krijgsman O; Chandrasekaran G; Berns A; van Lohuizen M
Cancer Res Commun; 2024 Jan; 4(1):18-27. PubMed ID: 38054839
[TBL] [Abstract] [Full Text] [Related]
6. Contribution of bap1 loss and p16 (CDKN2A) deletion analysis to the definitive diagnosis of mesothelioma in effusion cytology.
Aydogdu G; Özekinci S
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):10001-10007. PubMed ID: 37916370
[TBL] [Abstract] [Full Text] [Related]
7. New developments in mesothelial pathology.
Churg A
Histopathology; 2024 Jan; 84(1):136-152. PubMed ID: 37694811
[TBL] [Abstract] [Full Text] [Related]
8. Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma.
Mitchell OD; Gilliam K; Del Gaudio D; McNeely KE; Smith S; Acevedo M; Gaduraju M; Hodge R; Ramsland ASS; Segal J; Das S; Hathaway F; Bryan DS; Tawde S; Galasinski S; Wang P; Tjota MY; Husain AN; Armato SG; Donington J; Ferguson MK; Turaga K; Churpek JE; Kindler HL; Drazer MW
JAMA Netw Open; 2023 Aug; 6(8):e2327351. PubMed ID: 37556141
[TBL] [Abstract] [Full Text] [Related]
9. Comparison of immunohistochemical mesothelial biomarkers in paired biopsies and effusion cytology cell blocks from pleural mesothelioma.
Mansour MSI; Huseinzade A; Seidal T; Hejny K; Maty A; Taheri-Eilagh F; Mager U; Dejmek A; Dobra K; Brunnström H
Cytopathology; 2023 Sep; 34(5):456-465. PubMed ID: 37337638
[TBL] [Abstract] [Full Text] [Related]
10. Clinically Occult Diffuse Pleural Mesothelioma in Patients Presenting With Spontaneous Pneumothorax.
Fels Elliott DR; Konopka KE; Hrycaj SM; Lagisetty KH; Myers JL; Farver CF; Huang T
Am J Clin Pathol; 2023 Sep; 160(3):322-330. PubMed ID: 37256702
[TBL] [Abstract] [Full Text] [Related]
11. New Markers for Management of Mesothelioma.
Nash A; Firth Née Phan T; Creaney J
Semin Respir Crit Care Med; 2023 Aug; 44(4):491-501. PubMed ID: 37253383
[TBL] [Abstract] [Full Text] [Related]
12. Diffuse intrapulmonary mesothelioma mimicking pulmonary lepidic adenocarcinoma: a rare case report and review of the literature.
RanYue W; ChunYan W; Likun H; LiPing Z; JieLu L; ZhengWei D
Diagn Pathol; 2023 May; 18(1):64. PubMed ID: 37194050
[TBL] [Abstract] [Full Text] [Related]
13. Characterizing the distribution of alterations in mesothelioma and their correlation to morphology.
Chen-Yost HI; Tjota MY; Gao G; Mitchell O; Kindler H; Segal J; Husain AN; Mueller J; Schulte JJ
Am J Clin Pathol; 2023 Sep; 160(3):238-246. PubMed ID: 37141416
[TBL] [Abstract] [Full Text] [Related]
14. The cytological features of effusions with mesothelioma in situ: A report of 9 cases.
Michael CW; Bedrossian CCWM; Sadri N; Klebe S
Diagn Cytopathol; 2023 Jun; 51(6):374-388. PubMed ID: 36942732
[TBL] [Abstract] [Full Text] [Related]
15. Utility of bap1, p16, and Methylthio-Adenosine Phosphorylase Immunohistochemistry in Cytological and Histological Samples of Pleural Mesotheliomas.
Amacher V; Bode PK; Moch H; Lenggenhager D; Vrugt B
Acta Cytol; 2023; 67(4):444-450. PubMed ID: 36889303
[TBL] [Abstract] [Full Text] [Related]
16. Mesotheliomas and Benign Mesothelial Tumors: Update on Pathologic and Imaging Findings.
Bonde A; Singh R; Prasad SR; Kamireddy D; Aggarwal A; Ramani N; Saboo S; Shanbhogue K; Dasyam AK; Katabathina VS
Radiographics; 2023 Mar; 43(3):e220128. PubMed ID: 36757881
[TBL] [Abstract] [Full Text] [Related]
17. The Rocky Road from Preclinical Findings to Successful Targeted Therapy in Pleural Mesothelioma.
Paajanen J; Bueno R; De Rienzo A
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362209
[TBL] [Abstract] [Full Text] [Related]
18. Diagnostic capacity of bap1 and MTAP in cytology from effusions and biopsy in mesothelioma.
Lynggård LA; Panou V; Szejniuk W; Røe OD; Meristoudis C
J Am Soc Cytopathol; 2022; 11(6):385-393. PubMed ID: 35945149
[TBL] [Abstract] [Full Text] [Related]
19. Co-Localization of Gastrointestinal Stromal Tumors (GIST) and Peritoneal Mesothelioma: A Case Series.
Courelli AS; Sharma AK; Madlensky L; Choi YY; Li S; Sarno S; Kelly K; Mehtsun W; Horgan S; Harismendy O; Baumgartner JM; Sicklick JK
Ann Surg Oncol; 2022 Nov; 29(12):7542-7548. PubMed ID: 35849291
[TBL] [Abstract] [Full Text] [Related]
20. Pleural mesothelioma.
Porcel JM
Med Clin (Barc); 2022 Sep; 159(5):240-247. PubMed ID: 35636988
[TBL] [Abstract] [Full Text] [Related]
[Next]
